Publications
Found 1 results
Filters: Author is A. Stachura [Clear All Filters]
“Sequence analysis of the regulatory region of the TNF-RII gene in Polish Holstein-Friesian cows”, vol. 12. pp. 1028-1034, 2013.
, Bensen JT, Langefeld CD, Li L, McCall CE, et al. (2003). Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression. Kidney Int. 63: 1211-1219.
http://dx.doi.org/10.1046/j.1523-1755.2003.00856.x
PMid:12631337
Bloomfield CD, Garson OM, Volin L, Knuutila S, et al. (1985). t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic-clinicopathologic association. Blood 66: 1409-1413.
PMid:4063527
Conne B, Stutz A and Vassalli JD (2000). The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat. Med. 6: 637-641.
http://dx.doi.org/10.1038/76211
PMid:10835679
Danckwardt S, Hentze MW and Kulozik AE (2008). 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 27: 482-498.
http://dx.doi.org/10.1038/sj.emboj.7601932
PMid:18256699 PMCid:2241648
Herbein G and O'Brien WA (2000). Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223: 241-257.
http://dx.doi.org/10.1046/j.1525-1373.2000.22335.x
PMid:10719836
Müller H and Helin K (2000). The E2F transcription factors: key regulators of cell proliferation. Biochim. Biophys. Acta 1470: M1-12.
PMid:10656985
Nishimura M, Maeda M, Matsuoka M, Mine H, et al. (2000). Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum. Immunol. 61: 1262-1269.
http://dx.doi.org/10.1016/S0198-8859(00)00182-8
Phillips AC, Ernst MK, Bates S, Rice NR, et al. (1999). E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 4: 771-781.
http://dx.doi.org/10.1016/S1097-2765(00)80387-1
Puga I, Lainez B, Fernández-Real JM, Buxadé M, et al. (2005). A polymorphism in the 3' untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression. Endocrinology 146: 2210-2220.
http://dx.doi.org/10.1210/en.2004-1366
PMid:15677760
Smith AJ and Humphries SE (2009). Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 20: 43-59.
http://dx.doi.org/10.1016/j.cytogfr.2008.11.006
PMid:19038572
Thome M, Schneider P, Hofmann K, Fickenscher H, et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
http://dx.doi.org/10.1038/386517a0
PMid:9087414
Trentin L, Zambello R, Agostini C, Siviero F, et al. (1993). Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood 81: 752-758.
PMid:8381309
Tsukasaki K, Miller CW, Kubota T, Takeuchi S, et al. (2001). Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 61: 3770-3774.
PMid:11325850
Yang YC, Hsu TY, Lin RH, Su IJ, et al. (2002). Resistance to tumor necrosis factor-alpha-induced apoptosis in human T-lymphotropic virus type I-infected T cell lines. AIDS Res. Hum. Retroviruses 18: 207-212.
http://dx.doi.org/10.1089/08892220252781266
PMid:11839155
Zhou Q, Snipas S, Orth K, Muzio M, et al. (1997). Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272: 7797-7800.
http://dx.doi.org/10.1074/jbc.272.12.7797
PMid:9065443